Abstract:figure legend We determined how physiological extremes of O2 and CO2 impact redox regulation of cerebral bioenergetic function. World‐class breath‐hold divers performed two maximal apnoeas resulting in hypoxaemic hypercapnia (prior normoxic normoventilation) and hyperoxaemic hypercapnia (prior hyperoxic hyperventilation). Transcerebral exchange of ascorbate free radicals (A•−) and nitric oxide metabolites were calculated as the product of global cerebral blood flow (gCBF) and radial arterial (a) to internal jugular venous (v) concentration gradients. Cerebral output (v > a) of A•− was enhanced in hypoxaemic hypercapnia and coincided with greater suppression of plasma nitrite (NO2−) uptake (a > v), gCBF and cerebral metabolic rate of glucose (gCMRGlu), implying reduced consumption and delivery of NO consistent with elevated cerebral oxidative–nitrosative stress (OXNOS). Abbreviations: ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; VA, vertebral artery. Summary interpretation: these findings highlight a key catalytic role for hypoxaemia in cerebral OXNOS, with NO2− reduction most probably serving as the dominant vasoactive mechanism. Figure created using Biorender (https://biorender.com/). We examined the extent to which apnoea‐induced extremes of oxygen demand/carbon dioxide production impact redox regulation of cerebral bioenergetic function. Ten ultra‐elite apnoeists (six men and four women) performed two maximal dry apnoeas preceded by normoxic normoventilation, resulting in severe end‐apnoea hypoxaemic hypercapnia, and hyperoxic hyperventilation designed to ablate hypoxaemia, resulting in hyperoxaemic hypercapnia. Transcerebral exchange of ascorbate radicals (by electron paramagnetic resonance spectroscopy) and nitric oxide metabolites (by tri‐iodide chemiluminescence) were calculated as the product of global cerebral blood flow (by duplex ultrasound) and radial arterial (a) to internal jugular venous (v) concentration gradients. Apnoea duration increased from 306 ± 62 s during hypoxaemic hypercapnia to 959 ± 201 s in hyperoxaemic hypercapnia (P ≤ 0.001). Apnoea generally increased global cerebral blood flow (all P ≤ 0.001) but was insufficient to prevent a reduction in the cerebral metabolic rates of oxygen and glucose (P = 0.015–0.044). This was associated with a general net cerebral output (v > a) of ascorbate radicals that was greater in hypoxaemic hypercapnia (P = 0.046 vs. hyperoxaemic hypercapnia) and coincided with a selective suppression in plasma nitrite uptake (a > v) and global cerebral blood flow (P = 0.034 to <0.001 vs. hyperoxaemic hypercapnia), implying reduced consumption and delivery of nitric oxide consistent with elevated cerebral oxidative–nitrosative stress. In contrast, we failed to observe equidirectional gradients consistent with S‐nitrosohaemoglobin consumption and plasma S‐nitrosothiol delivery during apnoea (all P ≥ 0.05). Collectively, these findings highlight a key catalytic role for hypoxaemic hypercapnia in cerebral oxidative–nitrosative stress. Key points Local sampling of blood across the cerebral circulation in ultra‐elite apnoeists determined the extent to which severe end‐apnoea hypoxaemic hypercapnia (prior normoxic normoventilation) and hyperoxaemic hypercapnia (prior hyperoxic hyperventilation) impact free radical‐mediated nitric oxide bioavailability and global cerebral bioenergetic function. Apnoea generally increased the net cerebral output of free radicals and suppressed plasma nitrite consumption, thereby reducing delivery of nitric oxide consistent with elevated oxidative–nitrosative stress. The apnoea‐induced elevation in global cerebral blood flow was insufficient to prevent a reduction in the cerebral metabolic rates of oxygen and glucose. Cerebral oxidative–nitrosative stress was greater during hypoxaemic hypercapnia compared with hyperoxaemic hypercapnia and coincided with a lower apnoea‐induced elevation in global cerebral blood flow, highlighting a key catalytic role for hypoxaemia. This applied model of voluntary human asphyxia might have broader implications for the management and treatment of neurological diseases characterized by extremes of oxygen demand and carbon dioxide production.

Extreme altitude‐induced central sleep apneas lasting more than 100 seconds in a healthy 23‐year‐old man

Severity of central sleep apnea does not affect sleeping oxygen saturation during ascent to high altitude

A Case of Behavioural Hyperventilation Associated with Severe Central Sleep Apnoea and Follow-Up Management

Assessing the contribution of mild high-altitude exposure to obstructive sleep apnea-hypopnea syndrome comorbidities

Effect of mild obstructive sleep apnea in mountaineers during the climb to Mount Aconcagua

Effects of periodic breathing on sleep at high altitude: a randomized, placebo‐controlled, crossover study using inspiratory CO2

1165 A Challenging Case of Chronic Fentanyl Use Inducing Central Sleep Apnea After Tracheostomy

1227 Spinal Stenosis as a Rare Cause of Central Sleep Apnea

Effectiveness of Continuous Positive Airway Pressure in Alleviating Hypoxemia and Improving Exertional Capacity at Altitude

Clinical, polysomnographic, and cephalometric features of obstructive sleep apnea with AHI over 100

The Effect of Different Elevation on the Patients with Sleep Apnea-Hypopnea Syndrome

A narrative review of periodic breathing during sleep at high altitude: From acclimatizing lowlanders to adapted highlanders

Sleep characteristics in an adult with sleep complaints in three cities at different altitudes

Heart rate variability during sleep at high altitude: effect of periodic breathing

1196 Use of Home Sleep Apnea Testing to Investigate Persistent Hypoxia in the Remote Setting

Resting-state functional magnetic resonance imaging of high altitude patients with obstructive sleep apnoea hypopnoea syndrome

1167 Chasing Centrals

Severe hypoxaemic hypercapnia compounds cerebral oxidative–nitrosative stress during extreme apnoea: Implications for cerebral bioenergetic function

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

1149 Unravelling the Mysteries of Pediatric Central Sleep Apnea (CSA): A Unique Case Report

The effect of high-altitude on the patients with sleep apnea syndrome